{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:42:08Z","timestamp":1793835728737,"version":"4.6.1"},"reference-count":196,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ekir.2026.106592","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:24:26Z","timestamp":1778765066000},"page":"106592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Beyond eGFR and Albuminuria: Biological Pathways and Multiomics in Cardiovascular\u2013Kidney\u2013Metabolic Disease"],"prefix":"10.1016","volume":"11","author":[{"given":"William R.","family":"Marshall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smeeta","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2026.106592_bib1","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2026.106592_bib2","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2026.106592_bib3","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ekir.2026.106592_bib4","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jamacardio.2023.3241","article-title":"Prevalence and overlap of cardiac, renal, and metabolic conditions in US adults, 1999\u20132020","volume":"8","author":"Ostrominski","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ekir.2026.106592_bib5","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106592_bib6","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106592_bib7","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106592_bib8","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Finerenone in patients with chronic kidney disease and type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106592_bib9","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106592_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106592_bib11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106592_bib12","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106592_bib13","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106592_bib14","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"American Heart Association. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2026.106592_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease","volume":"18","author":"Hasin","year":"2017","journal-title":"Genome Biol"},{"key":"10.1016\/j.ekir.2026.106592_bib16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.hfc.2014.04.008","article-title":"Phenotypic spectrum of heart failure with preserved ejection fraction","volume":"10","author":"Shah","year":"2014","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.ekir.2026.106592_bib17","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.kint.2025.01.041","article-title":"Risk stratification of metabolic disorder-associated kidney disease","volume":"107","author":"Xu","year":"2025","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106592_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ekir.2026.106592_bib19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.ekir.2026.106592_bib20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gutjnl-2020-323082","article-title":"Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ekir.2026.106592_bib21","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1136\/gutjnl-2021-325965","article-title":"Non-alcoholic fatty liver disease is a risk factor for cardiovascular and cardiac diseases: further evidence that a holistic approach to treatment is needed","volume":"71","author":"Targher","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ekir.2026.106592_bib22","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2337\/db06-0911","article-title":"Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation","volume":"56","author":"Hosogai","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.ekir.2026.106592_bib23","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ekir.2026.106592_bib24","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance","volume":"112","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ekir.2026.106592_bib25","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1161\/ATVBAHA.108.170316","article-title":"Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects","volume":"28","author":"Apovian","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ekir.2026.106592_bib26","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.jacc.2008.07.062","article-title":"Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus","volume":"52","author":"Rijzewijk","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ekir.2026.106592_bib27","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1136\/gutjnl-2021-325724","article-title":"Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort","volume":"71","author":"Simon","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ekir.2026.106592_bib28","doi-asserted-by":"crossref","first-page":"F817","DOI":"10.1152\/ajprenal.2000.278.5.F817","article-title":"Glomerular hemodynamics in severe obesity","volume":"278","author":"Chagnac","year":"2000","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ekir.2026.106592_bib29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.2011060627","article-title":"Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes","volume":"23","author":"Niewczas","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106592_bib30","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cmet.2019.08.003","article-title":"Mitochondrial damage and activation of the STING pathway lead to renal inflammation and fibrosis","volume":"30","author":"Chung","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.ekir.2026.106592_bib31","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1007\/s00018-021-03892-w","article-title":"The role of metabolic reprogramming in tubular epithelial cells during the progression of acute kidney injury","volume":"78","author":"Li","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ekir.2026.106592_bib32","first-page":"52","article-title":"Alteration of fatty acid oxidation in tubular epithelial cells: from acute kidney injury to renal fibrogenesis","volume":"2","author":"Simon","year":"2015","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ekir.2026.106592_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.ekir.2026.106592_bib34","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1681\/ASN.2015020177","article-title":"Mitochondrial pathology and glycolytic shift during proximal tubule atrophy after ischemic AKI","volume":"27","author":"Lan","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106592_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.109.931451","article-title":"Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction","volume":"4","author":"Westermann","year":"2011","journal-title":"Circ Heart Failure"},{"key":"10.1016\/j.ekir.2026.106592_bib36","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00018-022-04266-6","article-title":"Galectin-3 interferes with tissue repair and promotes cardiac dysfunction and comorbidities in a genetic heart failure model","volume":"79","author":"Vlachou","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ekir.2026.106592_bib37","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.hlc.2020.06.017","article-title":"Use of inflammatory biomarkers and real-time cardiac catheterisation to evaluate the left ventricular diastolic function in patients with diastolic heart failure","volume":"30","author":"Xu","year":"2021","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.ekir.2026.106592_bib38","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.jacc.2003.10.066","article-title":"Obesity and suppressed B-type natriuretic peptide levels in heart failure","volume":"43","author":"Mehra","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ekir.2026.106592_bib39","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1038\/s41598-025-88000-9","article-title":"Remnant cholesterol and its variability independent of low density lipoprotein cholesterol predict metabolic dysfunction associated steatotic liver disease","volume":"15","author":"Sun","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2026.106592_bib40","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.06.019","article-title":"KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease","volume":"98","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106592_bib41","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1007\/s00125-018-4691-2","article-title":"Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicentre study","volume":"61","author":"Penno","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.ekir.2026.106592_bib42","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1093\/eurheartj\/ehu254","article-title":"Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction","volume":"35","author":"Gori","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ekir.2026.106592_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.977938","article-title":"CVD risk in non-albuminuric chronic kidney disease in hypertensive, non-diabetic subjects: a post-hoc analysis from Sprint","volume":"9","author":"Sheng","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ekir.2026.106592_bib44","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/j.ajkd.2021.11.011","article-title":"Nonalbuminuric diabetic kidney disease and risk of all-cause mortality and cardiovascular and kidney outcomes in type 2 diabetes: findings from the Hong Kong diabetes Biobank","volume":"80","author":"Jin","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106592_bib45","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/eurheartj\/ehac528","article-title":"Albuminuria as a marker of systemic congestion in patients with heart failure","volume":"44","author":"Boorsma","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ekir.2026.106592_bib46","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.1007\/s11010-025-05379-9","article-title":"Inflammation in cardiovascular-kidney-metabolic syndrome: key roles and underlying mechanisms-a comprehensive review","volume":"480","author":"Xu","year":"2025","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.ekir.2026.106592_bib47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.ki.5002042","article-title":"Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study","volume":"71","author":"Keller","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106592_bib48","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/ndt\/gfv358","article-title":"Innate immunity in CKD-associated vascular diseases","volume":"31","author":"Zewinger","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106592_bib49","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1093\/eurheartj\/ehac444","article-title":"Inflammation drives residual risk in chronic kidney disease: a CANTOS substudy","volume":"43","author":"Ridker","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ekir.2026.106592_bib50","doi-asserted-by":"crossref","first-page":"F662","DOI":"10.1152\/ajprenal.00421.2009","article-title":"Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure","volume":"298","author":"Kim","year":"2010","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ekir.2026.106592_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1690443","article-title":"Inflammasomes as the molecular hub of cardiovascular-metabolic-immune comorbidity networks","volume":"16","author":"Qian","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.ekir.2026.106592_bib52","article-title":"The complement system in metabolic-associated kidney diseases","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ekir.2026.106592_bib53","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.ekir.2026.106592_bib54","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.ekir.2026.106592_bib55","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jamacardio.2021.3079","article-title":"Interleukin 6 and cardiovascular outcomes in patients with chronic kidney disease and chronic coronary syndrome","volume":"6","author":"Batra","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ekir.2026.106592_bib56","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12933-021-01409-0","article-title":"Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes","volume":"20","author":"Sharif","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ekir.2026.106592_bib57","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1007\/s001250050822","article-title":"NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X","volume":"40","author":"Pickup","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.ekir.2026.106592_bib58","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11897-025-00710-3","article-title":"Inflammatory biomarkers in heart failure: clinical perspectives on hsCRP, IL-6 and emerging candidates","volume":"22","author":"Kurt","year":"2025","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.ekir.2026.106592_bib59","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cyto.2011.09.029","article-title":"Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study","volume":"57","author":"Mirza","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.ekir.2026.106592_bib60","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/490842","article-title":"GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective","volume":"2015","author":"Adela","year":"2015","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.ekir.2026.106592_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124772","article-title":"Association between inflammation and cardiac geometry in chronic kidney disease: findings from the CRIC study","volume":"10","author":"Gupta","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2026.106592_bib62","article-title":"Elevated plasma levels of TNF-R1 predict the development of acute ischemic events in coronary patients with diabetes","volume":"37","author":"Mas-Fontao","year":"2025","journal-title":"Clin Investig Arterioscler"},{"key":"10.1016\/j.ekir.2026.106592_bib63","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1681\/ASN.0000000767","article-title":"Biomarkers of kidney failure and all-cause mortality in CKD","volume":"36","author":"Onoja","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106592_bib64","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2362.2002.00985.x","article-title":"Myocardial fibrosis in transforming growth factor-beta(1) (TGF-beta(1)) transgenic mice is associated with inhibition of interstitial collagenase","volume":"32","author":"Seeland","year":"2002","journal-title":"Eur J Clin Investigation"},{"key":"10.1016\/j.ekir.2026.106592_bib65","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.ekir.2026.106592_bib66","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","article-title":"Transforming growth factor (TGF)-\u03b2 signaling in cardiac remodeling","volume":"51","author":"Dobaczewski","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ekir.2026.106592_bib67","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2018.03.025","article-title":"GDF-15, galectin 3, soluble ST2, and risk of mortality and cardiovascular events in CKD","volume":"72","author":"Tuegel","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106592_bib68","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00392-010-0125-y","article-title":"Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study","volume":"99","author":"Lok","year":"2010","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ekir.2026.106592_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2024.107153","article-title":"Galectin-3 (Gal-3) and the tissue inhibitor of matrix metalloproteinase (TIMP-2) as potential biomarkers for the clinical evolution of chronic Chagas cardiomyopathy","volume":"252","author":"Menezes","year":"2024","journal-title":"Acta Trop"},{"key":"10.1016\/j.ekir.2026.106592_bib70","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12964-024-01527-8","article-title":"Crosstalk with renal proximal tubule cells drives acidosis-induced inflammatory response and dedifferentiation of fibroblasts via p38-singaling","volume":"22","author":"Schulz","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.ekir.2026.106592_bib71","doi-asserted-by":"crossref","first-page":"F431","DOI":"10.1152\/ajprenal.00171.2021","article-title":"Proximal tubule cyclophilin D mediates kidney fibrogenesis in obstructive nephropathy","volume":"321","author":"Jang","year":"2021","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ekir.2026.106592_bib72","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4103\/1319-2442.239657","article-title":"Chronic kidney disease in children: using novel biomarkers as predictors of disease","volume":"29","author":"Uwaezuoke","year":"2018","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.ekir.2026.106592_bib73","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5414\/CN109606","article-title":"The prevalence of normoalbuminuria and renal impairment in type 2 diabetes mellitus","volume":"92","author":"Pichaiwong","year":"2019","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ekir.2026.106592_bib74","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003011","article-title":"Plasma uromodulin correlates with kidney function and identifies early stages in chronic kidney disease patients","volume":"95","author":"Steubl","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ekir.2026.106592_bib75","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/j.ajkd.2015.07.025","article-title":"GFR estimation using \u03b2-trace protein and \u03b22-microglobulin in CKD","volume":"67","author":"Inker","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106592_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093460","article-title":"Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery","volume":"9","author":"Meersch","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2026.106592_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120863","article-title":"Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery","volume":"10","author":"Gocze","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2026.106592_bib78","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3904\/kjim.2018.266","article-title":"Urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 as biomarkers of patients with established acute kidney injury","volume":"35","author":"Cho","year":"2020","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.ekir.2026.106592_bib79","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/ckj\/sfad010","article-title":"TIMP-2 and IGFBP7 in human kidney biopsies in renal disease","volume":"16","author":"Schanz","year":"2023","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2026.106592_bib80","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-62246-1","article-title":"Urinary beta-2 microglobulin increases whereas TIMP-2 and IGFBP7 decline after unilateral nephrectomy in healthy kidney donors","volume":"14","author":"de Rooij","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2026.106592_bib81","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1172\/JCI75417","article-title":"KIM-1-mediated phagocytosis reduces acute injury to the kidney","volume":"125","author":"Yang","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ekir.2026.106592_bib82","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/path.2175","article-title":"Tubular kidney injury molecule-1 (KIM-1) in human renal disease","volume":"212","author":"van Timmeren","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.ekir.2026.106592_bib83","doi-asserted-by":"crossref","DOI":"10.1159\/000547867","article-title":"NURTuRE-CKD academic steering group. Plasma and urinary KIM-1 in chronic kidney disease: prognostic value, associations with albuminuria, and implications for kidney failure and mortality","author":"McDonnell","year":"2025","journal-title":"Am J Nephrol. Forthcoming"},{"key":"10.1016\/j.ekir.2026.106592_bib84","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.advms.2015.01.001","article-title":"High expression of neutrophil gelatinase-associated lipocalin (NGAL) in the kidney proximal tubules of diabetic rats","volume":"60","author":"Liu","year":"2015","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.ekir.2026.106592_bib85","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cca.2022.08.029","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) in kidney injury - A systematic review","volume":"536","author":"Marakala","year":"2022","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ekir.2026.106592_bib86","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12882-026-04791-7","article-title":"A longitudinal prospective study investigating serial measurements of plasma neutrophil gelatinase-associated lipocalins (NGAL) for the prediction of chronic kidney disease and acute kidney injury in emergency department patients","volume":"27","author":"Wetterstrand","year":"2026","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2026.106592_bib87","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/biom13020338","article-title":"Plasma neutrophil gelatinase-associated lipocalin associates with new-onset chronic kidney disease in the general population","volume":"13","author":"Bourgonje","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ekir.2026.106592_bib88","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fcell.2020.00336","article-title":"Urinary neutrophil gelatinase-associated lipocalin (NGAL) predicts renal function decline in patients with glomerular diseases","volume":"8","author":"Coppolino","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ekir.2026.106592_bib89","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.1038\/s41598-025-92315-y","article-title":"Biomarkers of cell cycle arrest, microcirculation dysfunction, and inflammation in the prediction of SA-AKI","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2026.106592_bib90","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2337\/db09-1630","article-title":"Reduction in basal nitric oxide activity causes albuminuria","volume":"60","author":"Ott","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.ekir.2026.106592_bib91","doi-asserted-by":"crossref","first-page":"F815","DOI":"10.1152\/ajprenal.00304.2024","article-title":"Endothelin-1 signaling in the kidney: recent advances and remaining gaps","volume":"328","author":"Brooks","year":"2025","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ekir.2026.106592_bib92","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1681\/ASN.2012010017","article-title":"Loss of the endothelial glycocalyx links albuminuria and vascular dysfunction","volume":"23","author":"Salmon","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106592_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1251876","article-title":"Endothelial cell activation and glycocalyx shedding - potential as biomarkers in patients with lupus nephritis","volume":"14","author":"Yung","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ekir.2026.106592_bib94","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1681\/ASN.2011121181","article-title":"Damage of the endothelial glycocalyx in dialysis patients","volume":"23","author":"Vlahu","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106592_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1372355","article-title":"Deciphering the triad of endothelial glycocalyx, von Willebrand factor, and P-selectin in inflammation-induced coagulation","volume":"12","author":"Ferreira","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ekir.2026.106592_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2024.108879","article-title":"Endothelial dysfunction markers syndecan-1 and thrombomodulin are associated with higher albuminuria levels in type 2 diabetes with no history of clinical cardiovascular disease","volume":"38","author":"Ferreira-Divino","year":"2024","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.ekir.2026.106592_bib97","article-title":"Mitochondrial dysfunction: the hidden catalyst in chronic kidney disease progression","volume":"47","author":"Chen","year":"2025","journal-title":"Ren Fail"},{"key":"10.1016\/j.ekir.2026.106592_bib98","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/cells12010088","article-title":"Oxidative stress and mitochondrial dysfunction in chronic kidney disease","volume":"12","author":"Ho","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ekir.2026.106592_bib99","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s41419-020-03122-4","article-title":"High-fat diet promotes renal injury by inducing oxidative stress and mitochondrial dysfunction","volume":"11","author":"Sun","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ekir.2026.106592_bib100","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3389\/fphys.2020.00732","article-title":"The vicious cycle of renal lipotoxicity and mitochondrial dysfunction","volume":"11","author":"Ge","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.ekir.2026.106592_bib101","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ekir.2024.10.035","article-title":"The role of mitochondria in diabetic kidney disease and potential therapeutic targets","volume":"10","author":"Takasu","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2026.106592_bib102","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cmet.2014.12.011","article-title":"Mitochondrial fission and fusion factors reciprocally orchestrate mitophagic culling in mouse hearts and cultured fibroblasts","volume":"21","author":"Song","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.ekir.2026.106592_bib103","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.3390\/cells11162481","article-title":"Mitochondrial dysfunction in individuals with diabetic kidney disease: a systematic review","volume":"11","author":"Flemming","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ekir.2026.106592_bib104","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.carpath.2015.09.009","article-title":"Impaired mitochondrial biogenesis is a common feature to myocardial hypertrophy and end-stage ischemic heart failure","volume":"25","author":"Pisano","year":"2016","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.ekir.2026.106592_bib105","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000542","article-title":"A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients","volume":"2","author":"Kalim","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ekir.2026.106592_bib106","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ki.2015.240","article-title":"Urinary mitochondrial DNA is a biomarker of mitochondrial disruption and renal dysfunction in acute kidney injury","volume":"88","author":"Whitaker","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106592_bib107","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41392-025-02329-1","article-title":"Organ cross-talk: molecular mechanisms, biological functions, and therapeutic interventions for diseases","volume":"11","author":"Che","year":"2026","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.ekir.2026.106592_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.696942","article-title":"Update on the crosstalk between adipose tissue and mineral balance in general population and chronic kidney disease","volume":"9","author":"Karava","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.ekir.2026.106592_bib109","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","article-title":"Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease","volume":"139","author":"Dushay","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ekir.2026.106592_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178971","article-title":"Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease","volume":"12","author":"Kohara","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2026.106592_bib111","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ekir.2026.106592_bib112","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2013050465","article-title":"Fibroblast growth factor-23 and cardiovascular events in CKD","volume":"25","author":"Scialla","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106592_bib113","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1681\/ASN.2017070772","article-title":"Longitudinal FGF23 trajectories and mortality in patients with CKD","volume":"29","author":"Isakova","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106592_bib114","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.3390\/biomedicines10102642","article-title":"New insights into adiponectin and leptin roles in chronic kidney disease","volume":"10","author":"Coimbra","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ekir.2026.106592_bib115","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/toxins17110525","article-title":"Leptin and adiponectin as uremic adipokines: associations with survival in a prospective hemodialysis cohort","volume":"17","author":"Bui","year":"2025","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.ekir.2026.106592_bib116","first-page":"204","article-title":"Leptin-to-adiponectin ratio is related to low grade inflammation and insulin resistance independent of obesity in non-diabetic Taiwanese: a cross-sectional cohort study","volume":"30","author":"Chou","year":"2014","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.ekir.2026.106592_bib117","article-title":"Elevated serum leptin, adiponectin and leptin to adiponectin ratio is associated with chronic kidney disease in Asian adults","volume":"10","author":"Lim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2026.106592_bib118","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1038\/s41467-025-59997-4","article-title":"Multiomic analysis of human kidney disease identifies a tractable inflammatory and pro-fibrotic tubular cell phenotype","volume":"16","author":"Reck","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.ekir.2026.106592_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2025.151584","article-title":"Multi-omics integration in nephrology: advances, challenges, and future directions","volume":"44","author":"Saliba","year":"2024","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ekir.2026.106592_bib120","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1159\/000508051","article-title":"KIM-1 and kidney disease progression in autosomal dominant polycystic kidney disease: HALT-PKD results","volume":"51","author":"Griffin","year":"2020","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2026.106592_bib121","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1681\/ASN.2016080919","article-title":"Growth differentiation Factor-15 and risk of CKD progression","volume":"28","author":"Nair","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106592_bib122","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1016\/j.ekir.2025.07.004","article-title":"GDF-15 and uEGF independently associate with CKD progression in children","volume":"10","author":"Bartels","year":"2025","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2026.106592_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117725","article-title":"Clinical value of serum MMP-3 in chronic kidney disease","volume":"553","author":"Fu","year":"2024","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ekir.2026.106592_bib124","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1681\/ASN.2013070758","article-title":"Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes","volume":"25","author":"Sabbisetti","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106592_bib125","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ki.2014.330","article-title":"Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes","volume":"87","author":"Pavkov","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106592_bib126","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41467-025-66490-5","article-title":"Renal insulin-like growth factor binding-protein 7 is a critical promoter of progressive diabetic kidney disease","volume":"17","author":"Yu","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.ekir.2026.106592_bib127","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s10238-025-01989-1","article-title":"Integrative multi-omics profiling for early diagnosis, stratification and personalized management of chronic kidney disease: a new paradigm","volume":"26","author":"Li","year":"2025","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.ekir.2026.106592_bib128","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1053\/j.ajkd.2021.05.013","article-title":"Plasma kidney injury Molecule 1 in CKD: findings from the Boston Kidney biopsy cohort and CRIC studies","volume":"79","author":"Schmidt","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106592_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.111017","article-title":"Circulating tumor necrosis factor-related biomarkers predict kidney function decline in Japanese patients with diabetes: an observational cohort study","volume":"206","author":"Murakoshi","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ekir.2026.106592_bib130","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1007\/s00125-018-4641-z","article-title":"Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes","volume":"61","author":"Nowak","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.ekir.2026.106592_bib131","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2020.06.013","article-title":"The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease","volume":"307","author":"Feldreich","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ekir.2026.106592_bib132","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/ckj\/sfz137","article-title":"Tumor necrosis factor-\u03b1 blockade ameliorates diabetic nephropathy in rats","volume":"14","author":"Cheng","year":"2019","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2026.106592_bib133","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02864-1","article-title":"Effects of tumor necrosis factor-\u03b1 inhibition on kidney fibrosis and inflammation in a mouse model of aristolochic acid nephropathy","volume":"11","author":"Taguchi","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2026.106592_bib134","doi-asserted-by":"crossref","first-page":"F1335","DOI":"10.1152\/ajprenal.00509.2013","article-title":"Role of the TNF pathway in the progression of diabetic nephropathy in KK-A(y) mice","volume":"306","author":"Omote","year":"2014","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ekir.2026.106592_bib135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-023-06249-4","article-title":"GDF15 promotes weight loss by enhancing energy expenditure in muscle","volume":"619","author":"Wang","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ekir.2026.106592_bib136","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.34067\/KID.0001132021","article-title":"Collagen Type III and VI remodeling biomarkers are associated with kidney fibrosis in lupus nephritis","volume":"2","author":"Genovese","year":"2021","journal-title":"Kidney360"},{"key":"10.1016\/j.ekir.2026.106592_bib137","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfaf079","article-title":"Cardiometabolic protein expression levels and pathways associated with kidney function decline in older European adults with advanced kidney disease","volume":"18","author":"Aylward","year":"2025","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2026.106592_bib138","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033660","article-title":"Proteomic correlates and prognostic significance of kidney injury in heart failure with preserved ejection fraction","volume":"13","author":"Salman","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ekir.2026.106592_bib139","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.jacc.2024.07.013","article-title":"Reaffirmation of mechanistic proteomic signatures accompanying SGLT2 inhibition in patients with heart failure: a validation cohort of the EMPEROR program","volume":"84","author":"Packer","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ekir.2026.106592_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2026.101506","article-title":"Development of highly multiplex targeted proteomics assays in biofluids using a nominal mass ion trap massspectrometer","author":"Plubell","year":"2026","journal-title":"Mol Cell Proteomics. Forthcoming"},{"key":"10.1016\/j.ekir.2026.106592_bib141","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.3390\/jcm9103212","article-title":"PromarkerD predicts renal function decline in type 2 diabetes in the canagliflozin cardiovascular assessment study (CANVAS)","volume":"9","author":"Peters","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.ekir.2026.106592_bib142","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003190","article-title":"Metabolomic profiling identifies novel circulating biomarkers of mitochondrial dysfunction differentially elevated in heart failure with preserved versus reduced ejection fraction: evidence for shared metabolic impairments in clinical heart failure","volume":"5","author":"Hunter","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ekir.2026.106592_bib143","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3390\/cells11101674","article-title":"Metabolomic profiling in patients with heart failure and exercise intolerance: kynurenine as a potential biomarker","volume":"11","author":"Bekfani","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ekir.2026.106592_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2025.101009","article-title":"Plasma and urine metabolites associated with nondiabetic chronic kidney disease: the HELIUS study","volume":"7","author":"Mosterd","year":"2025","journal-title":"Kidney Med"},{"key":"10.1016\/j.ekir.2026.106592_bib145","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161696","article-title":"Metabolite profiling of CKD progression in the chronic renal insufficiency cohort study","volume":"7","author":"Wen","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.ekir.2026.106592_bib146","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/j.ajkd.2024.03.028","article-title":"Associations of urine and plasma metabolites with kidney failure and death in a chronic kidney disease cohort","volume":"84","author":"Steinbrenner","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106592_bib147","doi-asserted-by":"crossref","first-page":"6962","DOI":"10.3390\/ijms26146962","article-title":"Lipid accumulation and insulin resistance: bridging metabolic dysfunction-associated fatty liver disease and chronic kidney disease","volume":"26","author":"Cao","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ekir.2026.106592_bib148","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/ATVBAHA.111.241356","article-title":"Apolipoprotein B secretion is regulated by hepatic triglyceride, and not insulin, in a model of increased hepatic insulin signaling","volume":"32","author":"Moon","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ekir.2026.106592_bib149","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1172\/JCI32752","article-title":"Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents","volume":"118","author":"Ota","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ekir.2026.106592_bib150","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1161\/01.CIR.0000146898.06923.80","article-title":"Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and cardiovascular Health study","volume":"110","author":"M\u00e4rz","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2026.106592_bib151","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005549","article-title":"Atherogenic lipoprotein determinants of cardiovascular disease and residual risk among individuals with low low-density lipoprotein cholesterol","volume":"6","author":"Lawler","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ekir.2026.106592_bib152","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3803\/EnM.2015.30.2.208","article-title":"Apolipoprotein B is related to metabolic syndrome independently of low density lipoprotein cholesterol in patients with type 2 diabetes","volume":"30","author":"Lim","year":"2015","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.ekir.2026.106592_bib153","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCULATIONAHA.124.068885","article-title":"bridging the gap between evidence and clinical practice","volume":"150","author":"De Oliveira-Gomes","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2026.106592_bib154","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0021-9150(00)00484-6","article-title":"Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study","volume":"154","author":"McNamara","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ekir.2026.106592_bib155","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41591-022-01869-1","article-title":"Genome-wide polygenic score to predict chronic kidney disease across ancestries","volume":"28","author":"Khan","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ekir.2026.106592_bib156","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/jama.2019.22241","article-title":"Predictive accuracy of a polygenic risk score-enhanced prediction model vs a clinical risk score for coronary artery disease","volume":"323","author":"Elliott","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2026.106592_bib157","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.919374","article-title":"Associations between polygenic risk of coronary artery disease and type 2 diabetes, lifestyle, and cardiovascular mortality: a prospective UK Biobank study","volume":"9","author":"Yun","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ekir.2026.106592_bib158","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.2147\/JIR.S506760","article-title":"Gene editing: an effective tool for the future treatment of kidney disease","volume":"Volume","author":"Cao","year":"2025","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.ekir.2026.106592_bib159","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","article-title":"Clinical use of current polygenic risk scores may exacerbate health disparities","volume":"51","author":"Martin","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.ekir.2026.106592_bib160","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.ekir.2026.106592_bib161","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/ndt\/gfad086","article-title":"Urinary podocyte-derived large extracellular vesicles are increased in paediatric idiopathic nephrotic syndrome","volume":"38","author":"Myette","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106592_bib162","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.181937","article-title":"Endothelial extracellular vesicle miR-423-5p regulates microvascular homeostasis and renal function after ischemia-reperfusion injury","volume":"10","author":"Migneault","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.ekir.2026.106592_bib163","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-001101","article-title":"miR-196b-5p-enriched extracellular vesicles from tubular epithelial cells mediated aldosterone-induced renal fibrosis in mice with diabetes","volume":"8","author":"Hu","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.ekir.2026.106592_bib164","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41420-021-00670-2","article-title":"MicroRNA in extracellular vesicles regulates inflammation through macrophages under hypoxia","volume":"7","author":"Li","year":"2021","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.ekir.2026.106592_bib165","doi-asserted-by":"crossref","first-page":"9454","DOI":"10.3390\/ijms22179454","article-title":"Circulating microRNAs signature for predicting response to GLP1-RA therapy in Type 2 diabetic patients: a pilot study","volume":"22","author":"Formichi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ekir.2026.106592_bib166","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1681\/ASN.2013070763","article-title":"Urinary podocyte microparticles identify prealbuminuric diabetic glomerular injury","volume":"25","author":"Burger","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106592_bib167","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-08236-3","article-title":"Podocyte extracellular vesicles and immune mediators as urinary biomarkers in active lupus nephritis","volume":"15","author":"Alves","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2026.106592_bib168","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae224","article-title":"Multiomic profiling of new-onset kidney function decline: insights from the Stanislas study cohort with a 20-year follow-up","volume":"17","author":"Dupont","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2026.106592_bib169","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.186070","article-title":"Leveraging complementary multi-omics data integration methods for mechanistic insights in kidney diseases","volume":"10","author":"Alakwaa","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.ekir.2026.106592_bib170","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.3390\/ijms25116033","article-title":"Multi-Omic analysis reveals genetic determinants and therapeutic targets of chronic kidney disease and kidney function","volume":"25","author":"Lu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ekir.2026.106592_bib171","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/CIRCULATIONAHA.122.061481","article-title":"Aptamer proteomics for biomarker discovery in heart failure with reduced ejection fraction","volume":"146","author":"Zhang","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2026.106592_bib172","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033544","article-title":"Aptamer proteomics for biomarker discovery in heart failure with preserved ejection fraction: the Paragon-HF proteomic substudy","volume":"13","author":"Patel-Murray","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ekir.2026.106592_bib173","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1186\/s12864-024-10575-w","article-title":"Integrated proteomic and metabolomic profiling reveals novel insights on the inflammation and immune response in HFpEF","volume":"25","author":"Abudurexiti","year":"2024","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ekir.2026.106592_bib174","doi-asserted-by":"crossref","first-page":"H768","DOI":"10.1152\/ajpheart.00820.2016","article-title":"Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond","volume":"313","author":"Ruiz","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ekir.2026.106592_bib175","first-page":"188","article-title":"Trimethylamine N-oxide and cardiovascular outcomes in patients with chronic heart failure after myocardial infarction","volume":"7","author":"Zhou","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.ekir.2026.106592_bib176","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/CIRCULATIONAHA.122.061846","article-title":"Myocardial metabolomics of human heart failure with preserved ejection fraction","volume":"147","author":"Hahn","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2026.106592_bib177","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1243505","article-title":"Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease","volume":"14","author":"Lin","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ekir.2026.106592_bib178","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41586-019-1390-1","article-title":"A clinically applicable approach to continuous prediction of future acute kidney injury","volume":"572","author":"Toma\u0161ev","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ekir.2026.106592_bib179","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.jacc.2023.08.053","article-title":"Multiomics analysis provides novel pathways related to progression of heart failure","volume":"82","author":"Ouwerkerk","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ekir.2026.106592_bib180","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.kint.2024.01.012","article-title":"Unbiased kidney-centric molecular categorization of chronic kidney disease as a step towards precision medicine","volume":"105","author":"Reznichenko","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106592_bib181","first-page":"4765","article-title":"A unified approach to interpreting model predictions","volume":"30","author":"Lundberg","year":"2017","journal-title":"Adv Neural Inf Process Syst"},{"key":"10.1016\/j.ekir.2026.106592_bib182","article-title":"Prognostic value of high-sensitivity troponin in predicting long-term cardiovascular outcomes in patients with type 2 diabetes: a systematic review","volume":"17","author":"Shahid","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.ekir.2026.106592_bib183","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.hjc.2023.09.011","article-title":"High-sensitivity cardiac troponin I for cardiovascular risk stratification in apparently healthy individuals","volume":"75","author":"Farmakis","year":"2024","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.ekir.2026.106592_bib184","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jchf.2017.11.003","article-title":"High-sensitivity cardiac troponin and new-onset heart failure: a systematic review and meta-analysis of 67,063 patients with 4,165 incident heart failure events","volume":"6","author":"Evans","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ekir.2026.106592_bib185","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/s41591-021-01425-3","article-title":"Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial","volume":"27","author":"Harrison","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ekir.2026.106592_bib186","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/S0140-6736(18)31785-9","article-title":"Pegbelfermin (BMS-986036), a pegylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial","volume":"392","author":"Sanyal","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2026.106592_bib187","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2026.106592_bib188","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"Ziltivekimab in patients with chronic kidney disease and elevated hsCRP (RESCUE): a randomized, double-blind, placebo-controlled trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2026.106592_bib189","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/jamacardio.2025.4491","article-title":"Rationale, design, and baseline clinical characteristics of the ziltivekimab cardiovascular outcomes trial: interleukin-6 inhibition and atherosclerotic event rate reduction","volume":"11","author":"Ridker","year":"2026","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ekir.2026.106592_bib190","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/CIRCULATIONAHA.121.058910","article-title":"Initial decline (dip) in estimated glomerular filtration rate after initiation of dapagliflozin in patients with heart failure and reduced ejection fraction: insights from DAPA HF","volume":"146","author":"Adamson","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2026.106592_bib191","first-page":"253","article-title":"Metabolomics insights into the benefits of SGLT2 inhibitors in type 2 diabetes","volume":"17","author":"Kyriakidou","year":"2025","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.ekir.2026.106592_bib192","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.011980","article-title":"Metabolic effects of the SGLT2 inhibitor dapagliflozin in heart failure across the spectrum of ejection fraction","volume":"17","author":"Selvaraj","year":"2024","journal-title":"Circ Heart Failure"},{"key":"10.1016\/j.ekir.2026.106592_bib193","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.kint.2025.10.005","article-title":"Remodeling mechanistic trials for kidney disease: a multimodal, tissue-centered approach to understand the renal mechanism of action of semaglutide","volume":"109","author":"Pruijm","year":"2026","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106592_bib194","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12882-024-03576-0","article-title":"A randomised, two-arm (1:1 ratio), double blind, placebo controlled phase III trial to assess the efficacy, safety, cost and cost-effectiveness of rituximab in treating de novo or relapsing NS in patients with MCD\/FSGS (Turing)","volume":"25","author":"Willcocks","year":"2024","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2026.106592_bib195","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1681\/ASN.2021060794","article-title":"Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology","volume":"33","author":"Watts","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106592_bib196","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.kint.2023.11.022","article-title":"A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence","volume":"105","author":"Shirai","year":"2024","journal-title":"Kidney Int"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246802492602824X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246802492602824X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T09:31:16Z","timestamp":1785749476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246802492602824X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":196,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S246802492602824X"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106592","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond eGFR and Albuminuria: Biological Pathways and Multiomics in Cardiovascular\u2013Kidney\u2013Metabolic Disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}],"article-number":"106592"}}